At a glance
ClinicalIndex Comparison RecordN/ACompleted· 110 enrolled
Drug / intervention
Ropivacaine 0.75 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Perioperative Ropivacaine Wound Infusion in Laparoscopic Cholecystectomy. A Randomized Controlled Double-blind Trial
In Brief
A clinical study evaluating Ropivacaine 0.75 and Normal saline for Pain, Postoperative and Chronic Postoperative Pain. Completed, enrolled 110 participants across 2 sites.
Detailed Summary
The investigators hypothesis is that perioperative infusion of 0.75 ropivacaine in patients undergoing laparoscopic cholecystectomy may modify the intensity of postoperative pain or the analgesic consumption during the first 24 hours.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Postoperative, Chronic Postoperative Pain
CountriesGreece
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2010
First PostedJul 2011
Primary CompletionJan 2014
TodayJul 2026
First PostedJul 7, 2011
Enrollment StartMay 1, 2010
Primary CompletionJan 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.7 yearsPosted 15.0 years ago
Interventions
Ropivacaine 0.75drug
Normal salinedrug